Article
Genotyping of KRAS Mutational Status by the In-Check Lab-on-Chip Platform.
Sensors (Basel, Switzerland) - 5 Jan 2018
Guarnaccia Maria, Iemmolo Rosario, San Biagio Floriana, Alessi Enrico, Cavallaro Sebastiano
Abstract excerpt
The KRAS oncogene is involved in the pathogenesis of several types of cancer, particularly colorectal cancer (CRC). The most frequent mutations in this gene are associated with poor survival, increased tumor aggressiveness and resistance to therapy with anti-epidermal growth factor receptor (EGFR) antibodies. For this reason, KRAS mutation testing has become increasingly common in clinical practice for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
